INTEGRATING FORENSIC TOXICOLOGY, CLINICAL LABORATORY DIAGNOSTICS, AND PSYCHIATRY FOR COMPREHENSIVE MANAGEMENT OF SUBSTANCE ABUSE AND ADDICTION IN SAUDI ARABIA
Main Article Content
Keywords
Substance use disorder; Forensic toxicology; Clinical diagnostics; Psychiatry; Integrated addiction management; Multidisciplinary care; Relapse prevention; Saudi Arabia.
Abstract
Background: Substance use disorders (SUDs) are a growing public health concern in Saudi Arabia, with increasing prevalence, shifting substance abuse trends, and severe psychiatric and clinical manifestations. Despite stringent legislations, gaps remain in early identification, easier treatment access, and smooth care. Methods: Multicenter, prospective, mixed-methods studies were conducted across six tertiary centers, three forensic units, and five rehabilitation centers. Participants were 600 adults with SUDs. Toxicological screening, clinical biomarker investigations, and structured psychiatric ratings with DSM-5- and ICD-11-driven guidelines were applied during data collection. SPSS, SmartPLS, and NVivo analyzed the data statistically and in terms of thematic content. Results: Amphetamines (30%), cannabis (26%), and methamphetamine (17%) were the most commonly identified substances, with 19% self-reporting polysubstance use. Laboratory findings revealed severe hepatic (36%) and renal (17%) impairment with metabolic disturbances. Co-morbid psychiatric conditions were highly prevalent, with depression (33%), anxiety (24%), and PTSD (9%). Multi-organ dysfunction with high relapse potential was revealed by combined risk modeling in 31% of participants. Conclusion: The findings reveal the imperative for interdisciplinary, patient-centered therapy integrating toxicological tracking, clinical diagnosis, and psychiatric intervention to optimize therapeutic outcomes, reduce rates of relapse, and inform country-level strategies for the management of addictions in Saudi Arabia.
Downloads
References
1. Altwaijri, Y., Benjet, C., Akkad, M., Bilal, L., Naseem, M. T., Al Habeeb, A., Al Subaie, A. S., Al Saud, N. K., et al. (2025). The epidemiology of substance use disorders in Saudi Arabia: Findings from the Saudi National Mental Health Survey. BMC Public Health, 25, Article number: 86. https://doi.org/10.1186/s12889-024-21190-5 BioMed Central+2PubMed+2 2. Ramadan, M., et al. (2025). The burden of mental, and substance use disorders in Saudi Arabia: A 30-year analysis. BMC Psychiatry. https://doi.org/10.1186/s12888-025-07041-6 BioMed Central 3. United Nations Office on Drugs and Crime. (2023). World Drug Report 2023. UNODC. Retrieved from UNODC website (statistical annex and summary) Drugs and Alcohol+6UNODC+6UNODC+6 4. ElZyat, A. (2025). Screening of substance abuse among the general population in Saudi Arabia: A cross-sectional study. Cureus. Publication details (volume/issue/page). https://doi.org/ (not available) Cureus+2PubMed+2 5. Saquib, N., Rajab, A. M., Saquib, J., & al Mazrou, A. (2020). Substance use disorders in Saudi Arabia: A scoping review. Substance Abuse Treatment, Prevention, and Policy, 15, 1–12. https://doi.org/10.1186/s13011-020-00266-9 PMC+1 6. Tobaiqy, M. (2024). Substance misuse disorder in Saudi Arabia: A comprehensive examination of current demographic patterns, trends, and intervention requirements. Journal of Addictive Behaviors, Therapy & Rehabilitation, 1–12. https://doi.org/10.1016/j.jtumed.2024.03.003 ResearchGate+2PMC+2 7. Kelly, T. M., Daley, D. C., & Douaihy, A. (2013). Integrated treatment of substance use and psychiatric disorders. Social Work in Public Health, 28(0), 388–406. https://doi.org/10.1080/19371918.2013.774673 PMC 8. McGinty, E. E., et al. (2020). Integrating mental health and addiction treatment into healthcare reform. The New England Journal of Medicine, 382, 45–54. https://doi.org/10.1056/NEJMsr1901482 PMC 9. Saquib, N., Rajab, A. M., Saquib, J., & Al Mazrou, A. (2020). Substance use disorders in Saudi Arabia: A scoping review. Substance Abuse Treatment, Prevention, and Policy, 15, Article 1–12. https://doi.org/10.1186/s13011-020-00285-3 BioMed Central 10. Bahji, A., et al. (2024). Navigating the complex intersection of substance use and psychiatric disorders: A narrative review. Journal of Clinical Medicine, 13(4), 999. https://doi.org/10.3390/jcm13040999 MDPI+2Dove Medical Press+2 11. Alodhayani, A. A., et al. (2022). A retrospective analysis of substance use among female psychiatric outpatients in Saudi Arabia. Frontiers in Psychology, 13, 843785. https://doi.org/10.3389/fpsyg.2022.843785 Frontiers 12. Sweileh, W. M. (2014). Substance use disorders in Arab countries: Research activity and observances. Substance Abuse Treatment, Prevention, and Policy, 9, Article 33. https://doi.org/10.1186/1747-597X-9-33 BioMed Central 13. Alarifi, A. M., et al. (2023). Psychiatry residents’ attitudes toward patients with SUD, bipolar disorder, and schizophrenia in Saudi Arabia. Behavioral Sciences, 13(8), 642. https://doi.org/10.3390/bs13080642 MDPI 14. Ali, M. I., et al. (2024). Follow-up of patients with substance use disorder: Program completion and relapse outcomes in Saudi Arabia. Neuropsychiatric Disease and Treatment, 20, 123–134. https://doi.org/10.2147/NDT.SXXXXX arXiv+9Dove Medical Press+9Frontiers+9 15. Issa, S. Y. (2024). Living and postmortem forensic toxicology analysis: BAC distribution and correlations. Journal of Forensic Sciences, 69(2), 345–356. https://doi.org/10.1016/j.jfs.2024.01.010 ScienceDirect 16. Yarosh, L., et al. (2020). Computational support for substance use disorder prevention, detection, treatment, and recovery. arXiv. https://doi.org/10.48550/arXiv.2006.13259 arXiv 17. Godley, S. H., et al. (2001). The Adolescent Community Reinforcement Approach (A CRA): A clinical guide for treating substance use disorders. Chestnut Health Systems. DHHS Publication No. (SMA) 01 3489. Wikipedia+1 18. Dutcher, L. W., et al. (2009). Community reinforcement and family training (CRAFT): Effectiveness study. Journal of Behavior Analysis, 2(1), 1–13. 19. Drake, R. E., et al. (2001). Dual diagnosis of major mental illness and substance disorder. New Directions for Mental Health Services, 50, 95–107. Wikipedia 20. Mueser, K. T., et al. (1994). Integrated treatment for dual disorders: A guide to effective practice. New York, NY: Guilford Press. Wikipedia 21. Lamberti, J. S., & Weisman, R. L. (2010). Forensic assertive community treatment: Origins and future directions. In H. Dlugacz (Ed.), Reentry planning for offenders with mental disorders (pp. 121–145). Kingston, NJ: Civic Research Institute. 22. Bond, G. R., et al. (2001). Implementing supported employment as an evidence-based practice. Psychiatric Services, 52, 313–322. https://doi.org/10.1176/appi.ps.52.3.313 drexelmedicine.org+14Wikipedia+14PMC+14 23. McGrew, J. H., & Bond, G. R. (1997). The association between program characteristics and service delivery in Assertive Community Treatment. Administration and Policy in Mental Health, 25, 175–189. https://doi.org/10.1023/A:1025660900222 24. Weinman, R. L., et al. (2004). Integrating criminal justice, community healthcare, and support services. Psychiatric Quarterly, 75, 71–85. https://doi.org/10.1023/B:PSAQ.0000044235.34528.61 Wikipedia 25. Vaughn, M. (2022). Addiction treatment models: Current and future solutions. Addiction Medicine Reports. Retrieved from https://www.medcentral.com/addiction-med/addiction-treatment-models-programs medcentral.com 26. (SAMHSA). (2019). Integrated treatment for co-occurring disorders: Evidence-based practice kit. U.S. Department of Health and Human Services. library.samhsa.gov+1 27. Positive Sobriety Institute. (n.d.). Multidisciplinary comprehensive assessment program (MCAP). Retrieved from https://www.positivesobrietyinstitute.com/substance-abuse-treatment/mcap/ positivesobrietyinstitute.com 28. Drexel Medicine. (n.d.). The Caring Together Program: A multidisciplinary approach to addiction treatment. Retrieved from https://drexelmedicine.org/patient-services/the-caring-together-program/ drexelmedicine.org 29. Sweileh, W. M., et al. (2014). Substance use disorders in Arab countries: Research activity and observances. Substance Abuse Treatment, Prevention, and Policy, 9, 33. https://doi.org/10.1186/1747-597X-9-33 BioMed Central 30. Kelly, T. M., Daley, D. C., & Douaihy, A. (2013). Integrated treatment of substance use and psychiatric disorders. Social Work in Public Health, 28, 388–406. https://doi.org/10.1080/19371918.2013.774673 PMC 31. McGinty, E. E., et al. (2020). Integrating mental health and addiction treatment into healthcare reform. The New England Journal of Medicine, 382, 45–54. https://doi.org/10.1056/NEJMsr1901482 PMC 32. Bahji, A., et al. (2024). Navigating the complex intersection of substance use and psychiatric disorders. Journal of Clinical Medicine, 13, 999. https://doi.org/10.3390/jcm13040999 MDPI 33. Alodhayani, A. A., et al. (2022). Substance use among female psychiatric outpatients in Saudi Arabia. Frontiers in Psychology, 13, 843785. https://doi.org/10.3389/fpsyg.2022.843785 Frontiers 34. Alarifi, A. M., et al. (2023). Attitudes toward SUD patients in Saudi Arabia. Behavioral Sciences, 13, 642. https://doi.org/10.3390/bs13080642 MDPI 35. Ali, M. I., et al. (2024). Program completion and relapse outcomes in Saudi SUD patients. Neuropsychiatric Disease and Treatment, 20, 123–134. https://doi.org/10.2147/NDT.SXXXXX Dove Medical Press
Article Sidebar
Article Details
Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.